John Duan is an accomplished business leader with more than 15 years of experience in the pharmaceutical and biotech industries. He holds an MBA, Finance from NYU Stern School of Business and has worked in various prominent positions. As Senior Director, Neurology Emerging Indications at Alexion Pharmaceuticals, Inc., he oversees global strategic marketing, new product planning, commercial evaluation, forecasting, and marketing research. John has also served as the Global Commercial Lead at Takeda, the Head of Global Commercial Analysis at Astellas Pharma US, the Director of Latuda Commercial Insights and Analytics at Dainippon Sumitomo Pharma, the Director of Commercial Assessment at Savient Pharmaceuticals, Inc., and the Global New Product Director at Bayer Pharmaceuticals. With his extensive experience, John is a respected and known leader in his field.